AU2013317899A1 - Biodegradable microcapsules containing filling material - Google Patents

Biodegradable microcapsules containing filling material Download PDF

Info

Publication number
AU2013317899A1
AU2013317899A1 AU2013317899A AU2013317899A AU2013317899A1 AU 2013317899 A1 AU2013317899 A1 AU 2013317899A1 AU 2013317899 A AU2013317899 A AU 2013317899A AU 2013317899 A AU2013317899 A AU 2013317899A AU 2013317899 A1 AU2013317899 A1 AU 2013317899A1
Authority
AU
Australia
Prior art keywords
composition
microcapsules
therapeutic agent
shell
filling material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013317899A
Other languages
English (en)
Other versions
AU2013317899A8 (en
Inventor
Kinam Park
Christopher A. Rhodes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akina Inc
OHR Pharma LLC
Original Assignee
Akina Inc
OHR Pharma LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akina Inc, OHR Pharma LLC filed Critical Akina Inc
Publication of AU2013317899A1 publication Critical patent/AU2013317899A1/en
Publication of AU2013317899A8 publication Critical patent/AU2013317899A8/en
Priority to AU2018204552A priority Critical patent/AU2018204552A1/en
Priority to AU2020202735A priority patent/AU2020202735A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Dermatology (AREA)
AU2013317899A 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material Abandoned AU2013317899A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2018204552A AU2018204552A1 (en) 2012-09-20 2018-06-22 Biodegradable Microcapsules Containing Filling Material
AU2020202735A AU2020202735A1 (en) 2012-09-20 2020-04-23 Biodegradable Microcapsules Containing Filling Material

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261703723P 2012-09-20 2012-09-20
US61/703,723 2012-09-20
PCT/US2013/060922 WO2014047439A1 (en) 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2018204552A Division AU2018204552A1 (en) 2012-09-20 2018-06-22 Biodegradable Microcapsules Containing Filling Material

Publications (2)

Publication Number Publication Date
AU2013317899A1 true AU2013317899A1 (en) 2015-05-07
AU2013317899A8 AU2013317899A8 (en) 2015-05-28

Family

ID=50341971

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2013317899A Abandoned AU2013317899A1 (en) 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material
AU2018204552A Abandoned AU2018204552A1 (en) 2012-09-20 2018-06-22 Biodegradable Microcapsules Containing Filling Material
AU2020202735A Abandoned AU2020202735A1 (en) 2012-09-20 2020-04-23 Biodegradable Microcapsules Containing Filling Material

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2018204552A Abandoned AU2018204552A1 (en) 2012-09-20 2018-06-22 Biodegradable Microcapsules Containing Filling Material
AU2020202735A Abandoned AU2020202735A1 (en) 2012-09-20 2020-04-23 Biodegradable Microcapsules Containing Filling Material

Country Status (9)

Country Link
US (3) US20150265541A1 (https=)
EP (1) EP2897593A4 (https=)
JP (2) JP2015532928A (https=)
KR (1) KR20150090038A (https=)
AU (3) AU2013317899A1 (https=)
BR (1) BR112015006087A2 (https=)
HK (1) HK1214127A1 (https=)
MX (2) MX2015003665A (https=)
WO (1) WO2014047439A1 (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2538929A4 (en) 2010-02-25 2014-07-09 Univ Johns Hopkins DELAYED RELEASE OF THERAPIES IN A PART OF THE EYE
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
CA2863632C (en) 2012-01-19 2017-07-11 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
US8962577B2 (en) 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
JP6138904B2 (ja) 2012-03-16 2017-05-31 ザ・ジョンズ・ホプキンス・ユニバーシティー 活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
KR102310775B1 (ko) 2012-05-03 2021-10-07 칼라 파마슈티컬스, 인크. 개선된 점막 수송을 나타내는 제약 나노입자
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
AU2013256064B2 (en) 2012-05-03 2018-01-04 Alcon Inc. Pharmaceutical nanoparticles showing improved mucosal transport
AU2013256008B2 (en) 2012-05-04 2016-02-25 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
CN107635545A (zh) 2015-01-27 2018-01-26 约翰霍普金斯大学 用于增强粘膜表面处活性剂的输送的低渗水凝胶制剂
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
US20170273911A1 (en) * 2016-03-23 2017-09-28 Boston Scientific Scimed Inc. Injectable microspheres
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
EP3454862B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
EP4491236A3 (en) 2016-05-10 2025-04-02 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
RU2018145364A (ru) 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
EP3858835A1 (en) 2016-07-01 2021-08-04 G1 Therapeutics, Inc. Pyrimidine-based antiproliferative agents
CN109862945B (zh) * 2016-10-28 2022-03-08 联合利华知识产权控股有限公司 包含颗粒的个人护理组合物
BR112019008463B1 (pt) 2016-10-28 2022-06-07 Unilever Ip Holdings B.V. Composição para a higiene pessoal
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
EP4717317A2 (en) 2017-06-20 2026-04-01 C4 Therapeutics, Inc. N/o-linked degrons and degronimers for protein degradation
JP2021519337A (ja) 2018-03-26 2021-08-10 シー４ セラピューティクス， インコーポレイテッド Ｉｋａｒｏｓの分解のためのセレブロン結合剤
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
WO2020051532A2 (en) 2018-09-06 2020-03-12 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
EP3866773B1 (en) 2018-10-16 2024-08-28 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
WO2020149684A2 (ko) * 2019-01-18 2020-07-23 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
KR102272566B1 (ko) * 2019-01-18 2021-07-05 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
FR3091878B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de produits d’entretien avec des propriétés olfactives améliorées
FR3091877B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de detergence avec des propriétés olfactives améliorées
US12496279B2 (en) 2019-04-11 2025-12-16 The Johns Hopkins University Nanoparticles for drug delivery to brain
CN120172958A (zh) 2019-04-12 2025-06-20 C4医药公司 Ikaros和aiolos的三环降解物
WO2021168320A1 (en) 2020-02-20 2021-08-26 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
AU2021231898A1 (en) 2020-03-05 2022-10-27 C4 Therapeutics, Inc. Compounds for targeted degradation of BRD9
ES3048084T3 (en) 2020-05-19 2025-12-09 Pharmacosmos Holding As Cyclin-dependent kinase inhibiting compounds for the treatment of medical disorders
WO2022066774A1 (en) 2020-09-23 2022-03-31 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders
WO2024184188A1 (en) * 2023-03-03 2024-09-12 Danmarks Tekniske Universitet A method for preparing microparticles for drug delivery

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001388A (en) * 1973-06-14 1977-01-04 Alza Corporation Ophthalmological bioerodible drug dispensing formulation
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
AU2001298061A1 (en) * 2000-12-13 2003-07-09 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
BRPI0516308A2 (pt) * 2004-10-04 2010-06-15 Qlt Usa Inc composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida
JP4856881B2 (ja) * 2005-02-01 2012-01-18 川澄化学工業株式会社 薬剤徐放システム
KR20080059175A (ko) * 2005-09-07 2008-06-26 사우스웨스트 리서치 인스티튜트 방출속도가 향상된 생분해성 미립자 약제학적 제제
JP5201763B2 (ja) * 2007-02-28 2013-06-05 昇一 城武 異なる平均粒径サイズの粒子からなる混合微粒子カプセルの製造方法
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
CA2700356C (en) * 2007-09-27 2013-07-09 Akina, Inc. Sol-gel phase-reversible hydrogel templates and uses thereof
US20130316010A1 (en) * 2010-10-18 2013-11-28 Case Western Reserve University Polymeric microparticles

Also Published As

Publication number Publication date
MX2019002575A (es) 2019-10-30
US20200390715A1 (en) 2020-12-17
KR20150090038A (ko) 2015-08-05
JP2015532928A (ja) 2015-11-16
MX2015003665A (es) 2016-03-08
HK1214127A1 (zh) 2016-10-07
AU2020202735A1 (en) 2020-05-14
WO2014047439A1 (en) 2014-03-27
EP2897593A1 (en) 2015-07-29
BR112015006087A2 (pt) 2017-07-04
US20150265541A1 (en) 2015-09-24
AU2018204552A1 (en) 2018-07-12
EP2897593A4 (en) 2016-04-06
JP2019014729A (ja) 2019-01-31
US20180185296A1 (en) 2018-07-05
AU2013317899A8 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
US20200390715A1 (en) Biodegradable Microcapsules Containing Filling Material
CN103142459B (zh) 包括含有生物活性剂的聚合物的医疗装置和方法
Naraharisetti et al. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release
Bourges et al. Intraocular implants for extended drug delivery: therapeutic applications
Pacheco et al. Development of an injectable PHBV microparticles-GG hydrogel hybrid system for regenerative medicine
Mao et al. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres
Zheng et al. A protein delivery system: biodegradable alginate–chitosan–poly (lactic-co-glycolic acid) composite microspheres
Freitas et al. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases
EP2696851B1 (en) Multilayer thin film drug delivery device
Tan et al. Fabrication of double-walled microspheres for the sustained release of doxorubicin
Tamani et al. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Diprophylline dispersions
US11213490B2 (en) Encapsulation-free controlled protein release system
WO2013119183A1 (en) Methods of manufacturing core-shell microparticles, and microparticles formed thereof
Brunner et al. Performance of biodegradable microcapsules of poly (butylene succinate), poly (butylene succinate-co-adipate) and poly (butylene terephthalate-co-adipate) as drug encapsulation systems
Klose et al. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles
Singh et al. Effect of modifications in poly (lactide-co-glycolide)(PLGA) on drug release and degradation characteristics: A mini review
Iswandana et al. Formulation of chitosan tripolyphosphate-tetrandrine beads using ionic gelation method: in vitro and in vivo evaluation
Le et al. Penta-block copolymer microspheres: Impact of polymer characteristics and process parameters on protein release
Zhang et al. Injectable biodegradable microchamber array films for long-term delivery of glucocorticoids
Wischke et al. Degradable polymeric carriers for parenteral controlled drug delivery
AU2020202040A1 (en) Multilayer Biodegradable Microparticles For Sustained Release of Therapeutic Agents
CN103599075A (zh) 聚乙二醇—聚乳酸包载倍他米松二丙酸酯的缓释微球及其制备方法
Thananukul et al. Fabrication of functional micro-/nano-particles from biodegradable polymers and their use in cosmetic and biomedical applications
CN121177203A (zh) 一种用于内耳局部释药水凝胶及其制备方法
Tian et al. The vitro and vivo study of Poly (3-hydroxybutyrate) microspheres

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 29 , NO 17 , PAGE(S) 2501 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME AKINA, INC., APPLICATION NO. 2013317899, UNDER INID (71) ADD CO-APPLICANT OHR PHARMA, LLC.

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted